Company intelligence / Profile preview

Navega Mais

San Diego / La Jolla area*, California, United Statesnavegamais.com.br ↗

Ownership: Private
Development stage: Other

Overview

Navega Therapeutics is a preclinical-stage biotech developing non-addictive, epigenetic gene therapies for chronic pain and other complex diseases. Its lead program NT-Z001 targets NaV1.7 at the DNA level and has demonstrated proof-of-concept in five animal models of pain with completed safety studies in mice and non-human primates. The company is preparing to advance NT-Z001 into human clinical trials and has received significant grant funding from NIH and CIRM[2][6].

Therapeutic areas: OphthalmologyImmunologyNeurology
Modalities: Gene therapyEpigenetic gene therapyAAV-based gene therapy (Adeno-associated virus vector)
Industry: Biotech

Partnerships

Charles River Laboratories – CDMO/manufacturing partnership for GMP-grade AAV production for NT-Z001 and future programs [10]University of California San Diego – academic origin/spin-out [2]

Beyond the preview

Go deeper on Navega Mais.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navega Mais.

Explore the full profile